Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,887.32 /

-4.96 (-0.26%)

, AGIO

Agios Pharmaceuticals

$53.80 /

+0.01 (+0.02%)

08:12
01/23/20
01/23
08:12
01/23/20
08:12

American Society of Clinical Oncology to hold a symposium

2020 Gastrointestinal Cancers Symposium will be held in San Francisco on January 23-25.

AMZN

Amazon.com

$1,887.32 /

-4.96 (-0.26%)

AGIO

Agios Pharmaceuticals

$53.80 /

+0.01 (+0.02%)

AZN

AstraZeneca

$50.45 /

-0.345 (-0.68%)

BAYRY

Bayer

$0.00 /

+ (+0.00%)

BMY

Bristol-Myers

$67.42 /

-0.01 (-0.01%)

CELG

Bought by BMY

$0.00 /

+ (+0.00%)

DNA

Bought by RHHBY

$0.00 /

+ (+0.00%)

DSNKY

Daiichi Sankyo

$0.00 /

+ (+0.00%)

ERYP

Erytech Pharma

$7.23 /

+ (+0.00%)

ESALY

Eisai

$0.00 /

+ (+0.00%)

EXEL

Exelixis

$19.72 /

-0.04 (-0.20%)

FGEN

FibroGen

$43.78 /

+0.8 (+1.86%)

HSDEF

Harborside

$0.00 /

+ (+0.00%)

INCY

Incyte

$78.47 /

-0.22 (-0.28%)

LXRX

Lexicon

$3.77 /

-0.28 (-6.91%)

MRK

Merck

$89.65 /

-0.31 (-0.34%)

NTRA

Natera

$37.16 /

+0.01 (+0.03%)

NVTA

Invitae

$18.77 /

-0.025 (-0.13%)

PFE

Pfizer

$40.19 /

-0.17 (-0.42%)

PGNX

Progenics

$4.67 /

+0.015 (+0.32%)

SGEN

Seattle Genetics

$111.71 /

+3.04 (+2.80%)

TROV

Trovagene

$1.73 /

+0.18 (+11.61%)

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 27

    Jan

  • 27

    Jan

  • 27

    Jan

  • 28

    Jan

  • 30

    Jan

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

  • 06

    Feb

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 14

    Feb

  • 18

    Feb

  • 10

    Mar

  • 14

    Mar

  • 15

    Mar

  • 25

    Mar

  • 04

    Apr

  • 15

    May

  • 30

    May

AMZN Amazon.com
$1,887.32 /

-4.96 (-0.26%)

01/22/20 PIVT
Amazon.com price target raised to $2,250 from $2,100 at Pivotal Research
01/16/20 MSCO
Morgan Stanley boosts Amazon target to $2,200, says 2021 estimates 20% too low
01/15/20 MSCO
Microsoft widening lead as best positioned for hybrid cloud, says Morgan Stanley
01/23/20 WEDB
AWS goes to court to pause JEDI deal, decision to remain unchanged, says Wedbush
AGIO Agios Pharmaceuticals
$53.80 /

+0.01 (+0.02%)

12/11/19 PIPR
Agios Pharmaceuticals remains a favorite name at Piper Jaffray
12/17/19 PIPR
Agios Pharmaceuticals shares should be owned through 2020, says Piper Jaffray
01/02/20 GUGG
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/09/19 CANT
Cantor sees Agios trading up 5%-10% on mitapivat update
AZN AstraZeneca
$50.45 /

-0.345 (-0.68%)

01/22/20 OPCO
Amarin price target raised to $13 from $8 at Oppenheimer
01/13/20 ROTH
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
01/13/20 STFL
Amarin should rally on failure of two potential competitors, says Stifel
01/22/20 LIBR
Sanofi downgraded to Hold from Buy at Liberum (earlier)
BAYRY Bayer
$0.00 /

+ (+0.00%)

10/21/19 PIPR
Piper reiterates Overweight on Crispr Therapeutics with $100 price target
12/19/19 BOFA
Elanco upgraded to Buy from Neutral at BofA/Merrill
12/17/19 BREN
Bayer upgraded to Buy from Hold at Berenberg
12/17/19 BREN
Bayer upgraded to Buy from Hold at Berenberg
BMY Bristol-Myers
$67.42 /

-0.01 (-0.01%)

01/10/20 PIPR
Nektar update with Bristol-Myers 'positive all around,' says Piper Sandler
01/10/20 HCWC
Amended Nektar, Bristol pact reflects bempeg limitations, says H.C. Wainwright
01/06/20 SBSH
Bristol-Myers upgraded to Buy from Neutral on resumption at Citi
01/10/20 GSCO
Goldman keeps Sell on Nektar despite amended Bristol-Myers Squibb agreement
CELG Bought by BMY
$0.00 /

+ (+0.00%)

11/01/19 STPT
Celgene downgraded to Hold from Buy at Standpoint Research
11/01/19 BARD
Celgene downgraded d to Neutral from Outperform at Baird
11/01/19 BARD
Celgene downgraded to Neutral at Baird
09/23/19 GUGG
Agios Pharmaceuticals upgraded to Buy following selloff at Guggenheim
DNA Bought by RHHBY
$0.00 /

+ (+0.00%)

DSNKY Daiichi Sankyo
$0.00 /

+ (+0.00%)

12/09/19 JEFF
Daiichi Sankyo initiated with a Buy at Jefferies
ERYP Erytech Pharma
$7.23 /

+ (+0.00%)

09/05/19 JMPS
Erytech Pharma resumed with an Outperform at JMP Securities
ESALY Eisai
$0.00 /

+ (+0.00%)

09/17/19 DAIW
Eisai downgraded to Sell from Neutral at Daiwa
09/24/19 JEFF
Eisai initiated with a Buy at Jefferies
08/05/19 SBSH
Eisai upgraded to Neutral from Sell at Citi
10/24/19 NOMU
Eisai upgraded to Buy from Neutral at Nomura Instinet
EXEL Exelixis
$19.72 /

-0.04 (-0.20%)

11/13/19 BOFA
Exelixis initiated with a Buy at BofA/Merrill
01/12/20 PIPR
Exelixis shares to trade lower on guidance, says Piper Sandler
01/13/20 RHCO
Exelixis initiated with a Buy at SunTrust
FGEN FibroGen
$43.78 /

+0.8 (+1.86%)

11/12/19 STFL
FibroGen should be bought on yesterday's weakness, says Stifel
11/10/19 PIPR
Piper Jaffray sees approval for FibroGen's roxadustat, but still has concerns
11/11/19 MZHO
FibroGen price target raised to $72 from $65 at Mizuho
11/12/19 JEFF
Jefferies doesn't see 'anything new' in latest FibroGen short report
HSDEF Harborside
$0.00 /

+ (+0.00%)

INCY Incyte
$78.47 /

-0.22 (-0.28%)

01/14/20 JMPS
Incyte price target raised to $121 from $99 at JMP Securities
01/13/20 PIPR
Piper says terms of Incyte deal 'attractive' for Morphosys
01/23/20 CANT
Incyte price target raised to $83 from $65 at Cantor Fitzgerald
01/13/20 PIPR
Incyte deal with MorphoSys 'fits nicely,' says Piper Sandler
LXRX Lexicon
$3.77 /

-0.28 (-6.91%)

12/11/19 GABE
Lexicon downgraded to Hold on valuation at Gabelli
12/20/19 STFL
Stifel says Lexicon 'missed opportunity' with sotagliflozin data
12/11/19 GABE
Lexicon downgraded to Hold from Buy at Gabelli
11/08/19 SBSH
Lexicon downgraded to Neutral from Buy at Citi
MRK Merck
$89.65 /

-0.31 (-0.34%)

01/06/20 RBCM
Merck initiated with a Sector Perform at RBC Capital
12/18/19 MSCO
Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive
01/07/20 LEER
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
01/07/20
Fly Intel: Top five analyst initiations
NTRA Natera
$37.16 /

+0.01 (+0.03%)

12/19/19 CHLM
Natera kidney test to be covered under Medicare in February, says Craig-Hallum
12/19/19 PIPR
CareDx should be bought on weakness from Natera coverage, says Piper
11/07/19 CHLM
Natera price target raised to $49 from $37 at Craig-Hallum
11/11/19 ADAM
Natera results solid, remains a top pick at Canaccord
NVTA Invitae
$18.77 /

-0.025 (-0.13%)

11/27/19 OPCO
Invitae 2020 guidance could be set conservatively, says Oppenheimer
04/08/19 OPCO
Invitae price target raised to $30 from $21 at Oppenheimer
04/23/19 BNCH
UnitedHealth preferred lab launch a long-term plus for Invitae, says Benchmark
07/12/19 BNCH
Invitae price target raised to $26 after Jungla deal announcement at Benchmark
PFE Pfizer
$40.19 /

-0.17 (-0.42%)

01/14/20 LTCO
Axsome Therapeutics price target raised to $165 from $139 at Ladenburg
01/13/20 GUGG
Zymeworks named Best Idea at Guggenheim after Pfizer agreement
01/06/20 RBCM
Pfizer initiated with an Outperform at RBC Capital
PGNX Progenics
$4.67 /

+0.015 (+0.32%)

07/29/19 BRKL
Progenics initiated with a Buy at Brookline
10/02/19 FBCO
Lantheus deal for Progenics has 'some strategic merit,' says Credit Suisse
SGEN Seattle Genetics
$111.71 /

+3.04 (+2.80%)

12/19/19 STFL
Seattle Genetics price target raised to $101 from $87 at Stifel
12/20/19 PIPR
Seattle Genetics price target raised to $130 from $120 at Piper Jaffray
01/02/20 GUGG
Seattle Genetics downgraded to Neutral from Buy at Guggenheim
TROV Trovagene
$1.73 /

+0.18 (+11.61%)

03/01/19 MAXM
Trovagene price target lowered to $8 from $18 at Maxim

TODAY'S FREE FLY STORIES

General news
FX Action: USD-CAD has consolidated in the lower 1.3100s » 03:50
01/24/20
01/24
03:50
01/24/20
03:50

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: Narrow ranges have been seen » 03:25
01/24/20
01/24
03:25
01/24/20
03:25

FX Update: Narrow ranges…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Update: Narrow ranges have been seen » 03:15
01/24/20
01/24
03:15
01/24/20
03:15

FX Update: Narrow ranges…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Asian Market Update: » 01:50
01/24/20
01/24
01:50
01/24/20
01:50

Asian Market Update:…

Asian Market Update: Treasury yields are up 0.7 bp at 1.739% as Asian stock markets stabilised. Wall Street managed to claw back early losses to close little changed on Thursday and sentiment in Asia also improved somewhat, with most indices moving slightly higher, despite the spreading of the Wuhan coronavirus. Up to 10 cities across China are now reported to be in lockdown and the death-toll is rising. The number of cases outside of China is also rising although the WHO stepped short of declaring a Public Health Emergency of International Concern (PHEIC) yesterday, which helped to calm nerves. Mainland China bourses are now closed for the Lunar New Year holiday's, but the Hang Seng managed to move up 0.15%. Topix and Nikkei are down -0.06% and up 0.13% respectively and the ASX lifted 0.04%. U.S. futures are posting gains of around 0.1-0.2%. On the data front Japan core CPI came in a tad higher than expected and lifted to 0.7% from 0.5%, but this is still far below target. Australia PMI readings signaled continued decline in business activity, but after the strong employment report this week Westpac still dropped its rate cut forecast for February. USD-JPY is little changed at 109.53 and the front end WTI future is trading at USD 55.83 per barrel.

Syndicate
Applied Therapeutics 2.74M share Secondary priced at $45.50 » 23:52
01/23/20
01/23
23:52
01/23/20
23:52
APLT

Applied Therapeutics

$48.96 /

+0.6 (+1.24%)

The deal size was…

The deal size was increased from 1.75M shares and priced below the last close price of $48.85. Goldman Sachs, Cowen and UBS are acting as joint book running managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24
    Jan
Syndicate
Adaptive Biotechnologies 8M share Secondary priced at $26.50 » 23:50
01/23/20
01/23
23:50
01/23/20
23:50
ADPT

Adaptive Biotechnologies

$26.86 /

-0.34 (-1.25%)

JPMorgan, Goldman Sachs,…

JPMorgan, Goldman Sachs, BofA, Cowen, Guggenheim and William Blair are acting as joint book running managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24
    Jan
Hot Stocks
Pacific City Financial raises quarterly dividend to 10c from 8c per share » 20:43
01/23/20
01/23
20:43
01/23/20
20:43
PCB

Pacific City Financial

$15.41 /

+0.09 (+0.59%)

The dividend will be paid…

The dividend will be paid on or about March 13, 2020, to shareholders of record as of the close of business on February 28, 2020.

Earnings
Notable companies reporting before tomorrow's open » 20:25
01/23/20
01/23
20:25
01/23/20
20:25
AXP

American Express

$131.40 /

-0.16 (-0.12%)

, NEE

NextEra Energy

$260.00 /

+0.15 (+0.06%)

, SYF

Synchrony

$36.19 /

-0.23 (-0.63%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include NextEra Energy (NEE), consensus $1.50... American Express (AXP), consensus $2.01... Synchrony (SYF), consensus $1.07.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Trump to sign USMCA trade deal on Wednesday, Reuters says » 20:11
01/23/20
01/23
20:11
01/23/20
20:11
SPY

SPDR S&P 500 ETF Trust

$331.81 /

+0.41 (+0.12%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

President Donald Trump…

President Donald Trump will sign the U.S.-Mexico-Canada Agreement on trade in a White House ceremony next Wednesday, Reuters' Jeff Mason writes, citing a source with the administration. The official calls the agreement a "major accomplishment" for the President after he pledged to overhaul NAFTA as a political candidate, Mason writes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Investar Holding reports Q4 EPS 39c, consensus 48c » 19:36
01/23/20
01/23
19:36
01/23/20
19:36
ISTR

Investar Holding

$23.56 /

-0.48 (-2.00%)

Reports Q4 revenue…

Reports Q4 revenue $25.1M, consensus $18.88M. Reports Q4 net interest margin 3.44% vs. 3.53% last year. CEO John D'Angelo says: "Although we achieved a great deal during the quarter, our earnings were negatively impacted by additional provision expense of $0.2 million resulting from our strong loan growth which occurred late in the quarter, additional interest expense of $0.2 million on our $25.0 million subordinated debt, $0.2 million of legal expenses related to an acquired asset, $0.2 million of noninterest expense for our two new branches, and $0.3 million of additional expense for Louisiana Bank Shares Tax related to our growth."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Death toll related to China coronavirus has risen to 25 from 18, Bloomberg says  19:27
01/23/20
01/23
19:27
01/23/20
19:27
SPY

SPDR S&P 500 ETF Trust

$331.81 /

+0.41 (+0.12%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Turk Telekom upgraded to Buy from Neutral at Goldman Sachs » 19:11
01/23/20
01/23
19:11
01/23/20
19:11
TRKNY

Turk Telekom

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Vyacheslav Degtyarev upgraded Turk Telekom to Buy from Neutral with a price target of TRY 10.6, up from TRY 6.9. The analyst anticipates a gradual dividend restoration for the company in 2020 amid improved macro conditions, strengthened balance sheet, and "decent" profitability prospects.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Turk Telekom upgraded to Buy from Neutral at Goldman Sachs » 19:09
01/23/20
01/23
19:09
01/23/20
19:09
TRKNY

Turk Telekom

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Vyacheslav Degtyarev upgraded Turk Telekom to Buy and raised his price target to TRY10.6 from TRY6.9.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Heritage Commerce reports Q4 EPS 10c, consensus 24c » 19:06
01/23/20
01/23
19:06
01/23/20
19:06
HTBK

Heritage Commerce

$12.39 /

+0.01 (+0.08%)

"The fourth quarter…

"The fourth quarter of 2019 saw a significant accomplishment for Heritage Bank of Commerce with the completion of the Presidio Bank merger thereby creating the San Francisco Bay Area's premier community business bank with a strong depth of banking talent and an extensive and diverse customer base," said Keith A. Wilton, President and Chief Executive Officer. "Credit quality remains strong and the Bank continued to generate solid earnings for the fourth quarter and the full year of 2019, though these were partially reduced by anticipated merger-related costs from the Presidio merger."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Heritage Commerce increases quarterly dividend 8% to 13c per share » 19:05
01/23/20
01/23
19:05
01/23/20
19:05
HTBK

Heritage Commerce

$12.39 /

+0.01 (+0.08%)

Heritage Commerce Corp…

Heritage Commerce Corp announced that its Board of Directors increased its quarterly cash dividend 8% to $0.13 per share to holders of common stock. The dividend will be payable on February 19, 2020, to shareholders of record at close of business day on February 5, 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: After Hours Movers » 18:43
01/23/20
01/23
18:43
01/23/20
18:43
EHTH

eHealth

$97.09 /

-2.51 (-2.52%)

, TEAM

Atlassian

$132.89 /

+1.52 (+1.16%)

, INTC

Intel

$63.32 /

+0.53 (+0.84%)

, NXGN

NextGen Healthcare

$15.93 /

+0.04 (+0.25%)

, SIVB

SVB Financial

$259.41 /

+2.86 (+1.11%)

, FLR

Fluor

$19.97 /

+0.115 (+0.58%)

, AVGO

Broadcom

$319.73 /

+6.81 (+2.18%)

, DFS

Discover

$85.77 /

+0.405 (+0.47%)

, ISRG

Intuitive Surgical

$614.64 /

+4.41 (+0.72%)

, SWKS

Skyworks

$128.18 /

+3.18 (+2.54%)

, BANR

Banner Corp.

$54.20 /

+0.34 (+0.63%)

, ETFC

E-Trade

$46.07 /

-0.44 (-0.95%)

, CVTI

Covenant Transportation

$12.88 /

-0.3 (-2.28%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: eHealth (EHTH) up 15.6%... Atlassian (TEAM) up 9.7%... Intel (INTC) up 5.2%... NextGen Healthcare (NXGN) up 3.6%... SVB Financial (SIVB) up 3.1%. ALSO HIGHER: Fluor (FLR) up 7.8% after its Stork JV was awarded engineering services contract for Dutch assets... Broadcom (AVGO) up 2.3% after announcing new component deal with Apple. DOWN AFTER EARNINGS: Discover (DFS) down 5.8%... Intuitive Surgical (ISRG) down 2.9%... Skyworks (SWKS) down 2.5%... Banner Corp (BANR) down 2.2%... E-Trade (ETFC) down 2.1%... Covenant Transport (CVTI ) down 1.6%. Movers as of 18:30ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
GrubHub CEO: We haven't had any offers » 18:39
01/23/20
01/23
18:39
01/23/20
18:39
GRUB

GrubHub

$57.76 /

+1.395 (+2.48%)

In an interview on…

In an interview on CNBC's Mad Money, GrubHub CEO Matt Maloney discussed a Wall Street Journal story from earlier this month which claimed the company was weighing a possible sale. Maloney said, "We haven't had any offers to buy the company," and added that he had "no idea" where the WSJ sourced its information. Maloney said GrubHub was "revolutionizing pick up" with its new Ultimate technology solution for restaurants. He noted that the product has been evolving for five years and the company is working on several stadium deals. Maloney said the company's "large loyalty infrastructure" will assist in the roll-out of the new platform.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Axel Springer plans to delist from Frankfurt Stock Exchange » 18:22
01/23/20
01/23
18:22
01/23/20
18:22
AXELF

Axel Springer

$0.00 /

+ (+0.00%)

, KKR

KKR

$31.20 /

-0.29 (-0.92%)

Axel Springer (AXELF)…

Axel Springer (AXELF) plans to withdraw from the stock exchange. A respective application will be made at the Frankfurt Stock Exchange prior to the expiration of the acceptance period of the delisting offer. The withdrawal from the regulated market of the Frankfurt Stock Exchange requires a public delisting offer to the Axel Springer SE shareholders as a precondition so that shareholders can sell their shares prior to the termination of the stock listing. According to an agreement signed today with Axel Springer SE, KKR (KKR) will make such an offer with an offer price amounting to EUR63 in cash per share. This payment is equal to the offer price for the previous public tender offer which was closed in December 2019. In 2019, Axel Springer and KKR entered into an investment agreement for a strategic partnership aimed at supporting the long-term growth strategy. Through a public tender offer as well as additional purchases, KKR has acquired approximately 44.9% of Axel Springer's share capital. In the public tender offer document of 5 July 2019 KKR has already announced its intention to propose a delisting to the other consortium members and to the Executive Board of Axel Springer SE following the successful tender offer.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
GrubHub launches 'Ultimate technology' for restaurants » 18:20
01/23/20
01/23
18:20
01/23/20
18:20
GRUB

GrubHub

$57.76 /

+1.395 (+2.48%)

Grubhub launched its…

Grubhub launched its Ultimate technology, "a revolutionary, first-of-its-kind proprietary hardware and software solution that integrates all restaurant ordering channels into one system." Replacing error-prone handwritten scribbles and shouts, Ultimate is a digital workflow solution, connecting the front- and back-of-the house directly with diners and creating a transparent view into their order status - whether diners order for pickup or delivery on Grubhub, at an in-store kiosk, or directly with a cashier.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Noble Midstream raises quarterly dividend to 68.8c from 67.2c per share » 18:16
01/23/20
01/23
18:16
01/23/20
18:16
NBLX

Noble Midstream

$23.40 /

-0.75 (-3.11%)

The dividend will be…

The dividend will be payable on February 14, 2020 to unitholders of record as of February 4, 2019.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
SPDR Gold Shares holdings rise to 900.58MT from 898.82MT » 18:14
01/23/20
01/23
18:14
01/23/20
18:14
GLD

SPDR Gold Shares

$147.11 /

+0.33 (+0.22%)

This is the highest level…

This is the highest level of holdings since November 11th.

Periodicals
Sonos CEO apologizes for perceived 'planned obsolescence' move, Verge reports » 18:04
01/23/20
01/23
18:04
01/23/20
18:04
SONO

Sonos

$14.35 /

-0.115 (-0.80%)

Chris Welch of the Verge…

Chris Welch of the Verge writes that Sonos CEO Patrick Spence tried to "clear up an announcement" from earlier this week that stated the company will "cease delivering software updates and new features to its oldest products in May." Amid criticisms that the company was instigating a planned obsolescence, Sonos CEO Patrick Spence apologized "for any confusion" and reassured the company's customers "that the so-called legacy products," including the original Sonos Play:5, Zone Players, and Connect / Connect:Amp will "continue to work as they do today," according to the Verge story. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Carlyle's Rubenstein says eyeing 'relatively cheap' energy assets, Reuters says » 17:58
01/23/20
01/23
17:58
01/23/20
17:58
CG

Carlyle Group

$34.52 /

+0.24 (+0.70%)

Carlyle founder and…

Carlyle founder and co-executive chairman David Rubenstein said that worries about the future of energy assets have led to a selloff, but this has created "very good opportunities" for the private equity firm, Reuters' Divya Chowdhury and Aaron Saldanha report. Rubenstein told the Reuters Global Markets Forum that securing bank loans for such deals, however, have become more difficult. "Right now, energy is relatively cheap and therefore we are looking at lot of assets where there has been a sell-off in the value, in part because people are nervous about the future of carbon energy," he said. "So we still think there are very good opportunities there." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Insys founder sentenced to 66 months in prison over bribery scheme, Reuters says » 17:56
01/23/20
01/23
17:56
01/23/20
17:56
INSY

Insys Therapeutics

$0.00 /

+ (+0.00%)

Insys Therapeutics…

Insys Therapeutics founder John Kapoor has been sentenced to 66 months in prison for his role in a bribery and fraud scheme that ultimately played a role in the U.S. opioid crisis, Reuters' Tim McLaughlin reports. Kapoor is now the highest-ranking pharmaceutical executive to be sentenced in a case connected to the drug crisis, McLaughlin says. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Uber expects to begin operating in Vancouver soon, Bloomberg says » 17:52
01/23/20
01/23
17:52
01/23/20
17:52
UBER

Uber

$37.40 /

+0.33 (+0.89%)

Uber will finally start…

Uber will finally start operating in Vancouver, British Columbia, Bloomberg's Gerrit De Vynck reports. Vancouver was originally one of the ride-hailing giant's first targeted destinations outside of the U.S., but provincial authorities quickly rebuffed them, De Vynck notes. "We received authorization from the passenger transportation board to provide service across Metro Vancouver," Michael van Hemmen, an Uber spokesman, said at a press conference. "We expect to be available in the next few days." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.
友情链接:幸运飞艇官方开奖2020幸运飞艇计划网幸运飞艇走势图幸运飞艇历史开奖结果筛选